China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

9,616.17

7,176.24

7,956.50

6,775.51

7,876.32

5,582.59

6,737.21

Other Operating Income

0.00

Total Operating income

9,616.17

7,176.24

7,956.50

6,775.51

7,876.32

5,582.59

6,737.21

Raw Material Cost

4,531.23

3,562.90

3,801.49

3,325.61

4,040.14

2,876.25

3,233.97

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

35.76

32.30

27.89

21.68

14.58

22.34

22.30

Selling and Distribution Expenses

3,406.98

2,520.50

2,858.09

1,759.00

2,975.19

1,831.50

2,061.75

Other Expenses

33.28

28.99

25.21

8.83

25.06

13.90

14.61

Total Expenditure (Excl Depreciation)

8,306.79

6,405.55

6,939.58

5,194.56

7,280.52

4,869.10

5,464.12

Operating Profit (PBDIT) excl Other Income

1309.4

770.6999999999999

1016.9

1580.9

595.8

713.5

1273.1

Other Income

168.07

103.74

133.02

101.31

173.75

168.06

142.64

Operating Profit (PBDIT)

1,755.08

1,173.98

1,294.14

1,997.26

842.20

1,082.24

1,603.11

Interest

35.76

32.30

27.89

21.68

14.58

22.34

22.30

Exceptional Items

119.81

104.95

36.68

0.50

9.56

-2.26

2.40

Gross Profit (PBDT)

5,084.95

3,613.34

4,155.02

3,449.91

3,836.19

2,706.34

3,503.24

Depreciation

408.33

306.91

228.76

221.38

Profit Before Tax

1,430.81

838.30

996.02

1,669.18

608.43

828.89

1,361.84

Tax

166.80

117.51

80.80

333.00

75.98

157.78

232.13

Provisions and contingencies

0.00

Profit After Tax

1,068.17

537.57

545.18

1,270.07

408.06

561.47

1,034.53

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,068.17

537.57

545.18

1,270.07

408.06

561.47

1,034.53

Share in Profit of Associates

0.00

Minority Interest

198.49

150.14

335.03

61.30

124.97

106.19

89.35

Other related items

0.00

Consolidated Net Profit

1,266.67

687.71

880.21

1,331.38

533.02

667.66

1,123.89

Equity Capital

0.00

Face Value

1.0

Reserves

22,171.74

21,115.69

21,340.22

21,178.18

19,903.11

20,532.69

19,954.04

Earnings per share (EPS)

0.64

0.32

0.33

0.76

0.25

0.34

0.62

Diluted Earnings per share

0.64

0.32

0.33

0.76

0.25

0.34

0.62

Operating Profit Margin (Excl OI)

12.26%

9.22%

10.74%

23.45%

5.58%

12.28%

18.39%

Gross Profit Margin

19.13%

17.37%

16.38%

29.17%

10.63%

18.95%

23.5%

PAT Margin

11.11%

7.49%

6.85%

18.75%

5.18%

10.06%

15.36%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 34.00% vs -9.81% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 84.19% vs -21.87% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 48.29% vs -7.83% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 10.84% vs 15.77% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(CNY)

Change(%)

Net Sales

9,616.17

Other Operating Income

0.00

Total Operating income

9,616.17

Raw Material Cost

4,531.23

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

35.76

Selling and Distribution Expenses

3,406.98

Other Expenses

33.28

0.00

33.28

Total Expenditure (Excl Depreciation)

8,306.79

Operating Profit (PBDIT) excl Other Income

1,309.38

0.00

1,309.38

Other Income

168.07

Operating Profit (PBDIT)

1,755.08

Interest

35.76

Exceptional Items

119.81

Gross Profit (PBDT)

5,084.95

Depreciation

408.33

Profit Before Tax

1,430.81

Tax

166.80

Provisions and contingencies

0.00

Profit After Tax

1,068.17

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,068.17

Share in Profit of Associates

0.00

Minority Interest

198.49

Other related items

0.00

Consolidated Net Profit

1,266.67

Equity Capital

0.00

Face Value

1.00

0.00

Reserves

22,171.74

Earnings per share (EPS)

0.64

Diluted Earnings per share

0.64

Operating Profit Margin (Excl OI)

12.26%

0.00

12.26%

Gross Profit Margin

19.13%

0.00

19.13%

PAT Margin

11.11%

0.00

11.11%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 961.62 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 34.00% vs -9.81% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 22.09% vs 28.47% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 126.67 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 84.19% vs -21.87% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 137.65% vs 11.44% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 158.70 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 48.29% vs -7.83% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 137.43% vs 7.62% in Dec 2024

Quarterly - Interest

Interest 3.58 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 10.84% vs 15.77% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 145.21% vs -48.77% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 12.26%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024